Brian Conn
Directeur/Bestuurslid bij Biosensis Pty Ltd.
Profiel
Brian D.
Conn is currently a Director at Biosensis Pty Ltd.
He previously held positions as an Associate Director at Sandler O'Neill & Partners LP, Chief Financial Officer at EMD Millipore Corp., Serologicals Corp., Verdezyne, Inc., MicroIslet, Inc., and CHEMICON International, Inc. He also worked as an Analyst at RBC Capital Markets LLC.
Conn's education includes an undergraduate degree from Arizona State University.
He is currently serving as the Chief Financial & Accounting Officer at Ra Medical Systems, Inc. and has previously served as the Chief Financial Officer at Quantapore, Inc. and Imagion Biosystems Ltd.
Actieve functies van Brian Conn
Bedrijven | Functie | Begin |
---|---|---|
Biosensis Pty Ltd. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Brian Conn
Bedrijven | Functie | Einde |
---|---|---|
Quantapore, Inc.
Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Financieel Directeur/CFO | 01-12-2021 |
IMAGION BIOSYSTEMS LIMITED | Financieel Directeur/CFO | 01-07-2020 |
Verdezyne, Inc.
Verdezyne, Inc. Pharmaceuticals: OtherHealth Technology Verdezyne, Inc. operates as an industrial biotechnology company. It designs and engineers enzymes, metabolic pathways, and microorganisms that produce target chemicals. The firm offers Biolon DDDA, Adipic acid, and Sebacic Acid. The company was founded in 2005 and is headquartered in Carlsbad, CA. | Financieel Directeur/CFO | 01-02-2016 |
MicroIslet, Inc.
MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | Financieel Directeur/CFO | 01-01-2009 |
Serologicals Corp.
Serologicals Corp. Miscellaneous Commercial ServicesCommercial Services Serologicals Corp. researches, develops and markets biological products for the life sciences market. The firm focuses in areas such as are cell culture supplements, molecular reagents and diagnostic antibodies. Its applications include cardiology, hematology, infectious diseases, immunology, molecular biology and oncology. It has operations in Australia, Canada, Scotland, and United Kingdom. The company was founded in 1971 by Samuel A. Penninger and is located in Norcross, GA. | Financieel Directeur/CFO | 01-07-2006 |
Opleiding van Brian Conn
Arizona State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
IMAGION BIOSYSTEMS LIMITED | Health Technology |
Bedrijven in privébezit | 10 |
---|---|
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance RBC Capital Markets LLC is a full-service brokerage and financial services firm headquartered in New York City. They are a direct subsidiary of RBC USA Holdco Corp. and a wholly-owned indirect subsidiary of Royal Bank of Canada (TSE, NYSE: RY). Founded in 2010, the firm is comprised of 3 major business lines: the Private Client Group, the Fixed-Income Group and the Clearing and Execution Services Group. The Private Client Group serves individual investors, while the Fixed-Income Group provides services to institutions, municipalities and non-profit organizations. The Clearing and Execution Services Group is a provider of clearing and execution services to independent brokers/dealers throughout the US. RBC Capital Markets focuses on the following sectors: communications, media, consumer/retail, diversified industries, energy, financial institutions, forest products, healthcare, infrastructure finance, mining & metals, real estate, social infrastructure, technology and the US municipal markets. | Finance |
Sandler O'Neill & Partners LP
Sandler O'Neill & Partners LP Investment Banks/BrokersFinance Founded in 1988, Sandler O'Neill & Partners LP is a broker/dealer headquartered in New York City. The firm is a subsidiary of Sandler O'Neill & Partners Corp. and their ultimate parent is SOP Holdings LLC. Sandler O'Neill & Partners' Equity Sales & Trading team seeks to enhance liquidity, execute complex transactions, distribute securities and provide institutional investor exposure for hundreds of financial institutions. Sandler O'Neill is a market maker for over 425 NASDAQ financial stocks and trades equities on all active exchanges including the NYSE, NASDAQ, OTC Bulletin Board and Pink Sheets. They work with CEOs, CFOs and management teams on corporate buybacks, portfolio valuations, rebalancings and liquidations. Sandler O'Neill publishes detailed equity research on approximately 270 financial services companies. They primarily cover small- and mid-sized companies that are not widely followed by large Wall Street firms. Their research coverage focuses on the following industries: (1) banks and thrifts (2) specialty finance and credit card companies (3) asset management (4) e-Finance (5) investment banking firms and broker/dealers (6) REITS (7) mortgage REITs and (8) insurance. | Finance |
MicroIslet, Inc.
MicroIslet, Inc. Miscellaneous Commercial ServicesCommercial Services MicroIslet, Inc. operates as a biotechnology company, which researches, develops, and commercializes patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. The company was founded on August 21, 1998 and is headquartered in San Diego, CA. | Commercial Services |
Verdezyne, Inc.
Verdezyne, Inc. Pharmaceuticals: OtherHealth Technology Verdezyne, Inc. operates as an industrial biotechnology company. It designs and engineers enzymes, metabolic pathways, and microorganisms that produce target chemicals. The firm offers Biolon DDDA, Adipic acid, and Sebacic Acid. The company was founded in 2005 and is headquartered in Carlsbad, CA. | Health Technology |
CHEMICON International, Inc.
CHEMICON International, Inc. BiotechnologyHealth Technology CHEMICON International, Inc. manufactures & markets biological research products. Its products are used in fields such as life science & cell research, neuroscience, apoptosis (programmed cell death) and oncology. It also makes diagnostic tests that detect herpes, enter viruses and other infectious diseases. The company was founded in 1981 and is located in Temecula, CA. | Health Technology |
Serologicals Corp.
Serologicals Corp. Miscellaneous Commercial ServicesCommercial Services Serologicals Corp. researches, develops and markets biological products for the life sciences market. The firm focuses in areas such as are cell culture supplements, molecular reagents and diagnostic antibodies. Its applications include cardiology, hematology, infectious diseases, immunology, molecular biology and oncology. It has operations in Australia, Canada, Scotland, and United Kingdom. The company was founded in 1971 by Samuel A. Penninger and is located in Norcross, GA. | Commercial Services |
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Commercial Services |
Ra Medical Systems, Inc.
Ra Medical Systems, Inc. Medical SpecialtiesHealth Technology Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. Its product, the Destruction of Arteriosclerotic Blockages by laser Radiation Ablation (DABRA) laser and single-use catheter, together referred to as DABRA, is used as a tool in the treatment of peripheral artery disease which commonly occurs in the legs. The company was founded by Dean Irwin and Melissa Burstein on September 4, 2002 and is headquartered in Fort Mill, SC. | Health Technology |
Quantapore, Inc.
Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Health Technology |
Biosensis Pty Ltd. |